Why Did Bristol-Myers Squibb Co (BMY) Stock Rise 1.75% to $49.99?

Barclays has recently reduced Bristol-Myers Squibb Co (BMY) stock to Equal Weight rating, as announced on July 29, 2024, according to Finviz. Earlier, on March 11, 2024, Societe Generale had reduced the stock from a Buy to Hold. Redburn Atlantic also reduced Neutral rating with a price target of $54. Additionally, BofA Securities reduced Neutral […]

How Does EPAM Systems Inc (EPAM) Stack Up Against Its Industry Peers?

Deutsche Bank has recently initiated EPAM Systems Inc (EPAM) stock to Hold rating, as announced on August 22, 2024, according to Finviz. Earlier, on August 9, 2024, Itau BBA had raised the stock from a Underperform to Market Perform. Jefferies also raised Buy rating with a price target of $237. Additionally, Goldman initiated Neutral rating […]

Graphic Packaging Holding Company (GPK) Stock: More Strategic Than Meets the Eye

Stifel has recently initiated Graphic Packaging Holding Company (GPK) stock to Buy rating, as announced on July 9, 2024, according to Finviz. Earlier, on November 27, 2023, Raymond James had reduced the stock from a Strong Buy to Mkt Perform. BofA Securities also raised Buy rating. Additionally, Raymond James resumed Strong Buy rating on October […]

Cogent Biosciences Inc (COGT) Stock: Analyzing Its Quiet Power

Robert W. Baird has recently reduced Cogent Biosciences Inc (COGT) stock to Neutral rating, as announced on February 26, 2024, according to Finviz. Earlier, on February 8, 2024, Citigroup had initiated the stock to Buy, setting a price target of $11. Wedbush also reduced Neutral rating with a price target of $5. Additionally, JP Morgan […]

BXP Inc (BXP) Stock: Understanding Its Underlying Value

Deutsche Bank has recently initiated BXP Inc (BXP) stock to Hold rating, as announced on January 30, 2024, according to Finviz. Earlier, on January 2, 2024, Jefferies had raised the stock from a Hold to Buy, setting a price target of $80. for BXP stock. Wedbush also initiated Neutral rating with a price target of […]

Huntington Bancshares Incorporated (HBAN) Stock: More Robust Than the Numbers Suggest?

Robert W. Baird has recently reduced Huntington Bancshares Incorporated (HBAN) stock to Neutral rating, as announced on July 26, 2024, according to Finviz. Earlier, on June 14, 2024, Piper Sandler had reduced the stock from a Neutral to Underweight, setting a price target of $11.50. for HBAN stock. JP Morgan also raised Overweight rating with […]

Merck & Co Inc (MRK) Stock: Beyond the Surface of Its Performance?

Societe Generale has recently reduced Merck & Co Inc (MRK) stock to Sell rating, as announced on March 11, 2024, according to Finviz. Earlier, on January 4, 2024, TD Cowen had raised the stock from a Market Perform to Outperform, setting a price target of $135. for MRK stock. Deutsche Bank also initiated Buy rating […]